⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RGTX News
Defiance ETFs Surpass $8 Billion in Assets Under Management
globenewswire.com
LMNX
IRE
TRIL
IWMY
QQQY
SPYT
USOY
QQQT
WDTE
SMCX
SMST
GLDY
AIPO
DKNX
PLT
HIMY
HOOI
AMDU
SMCC
QLDY
OSCX
QBTZ
RGTZ
MST
SMCZ
PLTZ
IONZ
XMAG
ETHI
MSTX
AVGX
LLYX
NVOX
RIOX
SOFX
ORCX
IONX
HIMZ
RKLX
HOOX
RGTX
CVNX
SOUX
OKLL
VSTL
QPUX
LLYZ
ANEL
QSU
MPL
AVXX
HOOZ
BMNZ
DAMD
RKLZ
STSM
BU
OKLS
LNOK
SIXG
QTUM
JEDI
YBMN
Ractigen Therapeutics Announces First Patient Dosed in Phase II Clinical Trial of RAG-17 for SOD1-ALS
prnewswire.com
RGTX
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy
prnewswire.com
RGTX
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18 for Duchenne Muscular Dystrophy
prnewswire.com
RGTX